2021
Neurologic Manifestations of COVID-19
Delavari F, Varzaneh F, Rezaei N. Neurologic Manifestations of COVID-19. Advances In Experimental Medicine And Biology 2021, 1318: 343-353. PMID: 33973188, DOI: 10.1007/978-3-030-63761-3_20.Peer-Reviewed Original ResearchConceptsNeurological manifestationsPredisposition to multiple sclerosisPro-inflammatory stateManifestations of anosmiaCOVID-19 patientsAcute hemorrhagic encephalitisNeural invasionOlfactory bulbSystemic hyperinflammationNeurological symptomsSensory disturbanceAffected patientsAcute demyelinationManifestations rangeCerebrovascular injuryBrain stemHemorrhagic encephalitisGlial cellsMental statusEarly manifestationMultiple sclerosisNervous systemPatientsProlonged effectHyperinflammation
2019
The landscape of myeloid and astrocyte phenotypes in acute multiple sclerosis lesions
Park C, Ponath G, Levine-Ritterman M, Bull E, Swanson EC, De Jager PL, Segal BM, Pitt D. The landscape of myeloid and astrocyte phenotypes in acute multiple sclerosis lesions. Acta Neuropathologica Communications 2019, 7: 130. PMID: 31405387, PMCID: PMC6689891, DOI: 10.1186/s40478-019-0779-2.Peer-Reviewed Original ResearchConceptsMultiple sclerosis lesionsLesion rimAstrocyte phenotypeMyeloid cellsSclerosis lesionsActive multiple sclerosis lesionsAcute multiple sclerosis lesionsGlial activation markersActive MS lesionsNovel therapeutic targetDifferent lesion stagesPredominant cell typeAcute demyelinationDemyelinating lesionsCell typesActivation markersChronic inflammationDistinct myeloidCell-extrinsic factorsGlial cellsPhenotypic subsetsLesion stageGlial phenotypeMS lesionsLesion cells
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply